Overview


According to FutureWise analysis the market for Adhesion Barrier in 2023 is US$ 0.92 billion, and is expected to reach US$ 1.65 billion by 2031 at a CAGR of 7.50%.

Adhesion barriers are medical implants that can reduce abnormal internal scarring (adhesions) after surgery by separating internal tissues and organs during healing. Adhesion is a band of scar tissue forming between internal body surfaces that are not typically connected. These fibrous bands or sheets of tissue develop when the body's natural healing process tries to repair damage caused by various factors like surgery, infection, trauma, or radiation. These adhesions can appear as thick fibrous bands or thin sheets of tissue similar to plastic wrap. They are made from various materials, including synthetic polymers, hyaluronic acid-based gels, or collagen-based sheets. These barriers are typically applied during surgery, either as a gel, film, or sheet, and are placed between tissues or organs at risk of adhering to each other.

Peritoneal adhesions represent a crucial clinical challenge in gastrointestinal surgery. Peritoneal adhesions result from irritation of the peritoneum, which can occur due to infection or the physical trauma associated with surgery. They are a major cause of morbidity, resulting in multiple complications, many of which may be exemplified several years after the initial surgical procedure. Peritoneal adhesions are pathological bonds usually between the omentum, loops of the bowel, and the abdominal wall. These bonds can be a thick fibrous bridge containing blood vessels and nerve tissue, a thin film of connective tissue, or a direct contact between two organ surfaces.

FutureWise Market Research has published a report that provides an insightful adhesion barrier market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.

According to the analysis conducted by FutureWise research analysts, adhesion barrier market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Johnson & Johnson
  • Sanofi
  • Baxter International
  • C. R. Bard
  • Integra LifeSciences Holdings Corporation
  • Anika Therapeutics
  • Atrium Medical Corporation (A Part of Getinge Group)
  • FzioMed
  • MAST Biosurgery
  • Innocoll Holdings
  • Betatech Medical

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Developments in Adhesion Barrier Market:

  • In February 2023, B. Braun Melsungen AG announced the launch of AdheSeal in Europe. AdheSeal is a bioresorbable adhesion barrier designed to prevent adhesion formation after abdominal surgery.
  • In January 2023, Ethicon, Inc., a subsidiary of Johnson & Johnson, announced the launch of Seprafilm Ultra Adhesion Barrier in the United States. Seprafilm Ultra is a next-generation adhesion barrier designed to provide superior protection against adhesion formation.

The rising incidences of surgeries, driven by factors including the aging population and sports-related injuries due to growing sports participation, are expected to be a significant driver for the adhesion barrier market during the forecast period. The increased demand for surgical procedures necessitates using adhesion barriers to reduce post-operative complications and improve patient outcomes, forming favorable conditions for market growth. Additionally, the advancements in minimally invasive surgical procedures contribute to the demand for adhesion barriers. These techniques require smaller incisions and are associated with reduced post-operative adhesion formation, making adhesion barriers crucial for ensuring successful results in these procedures. Furthermore, the high cost of adhesion barrier products presents a significant hindrance to the market's growth over the forecast period. While effective in preventing post-surgical complications, these products often come with a substantial cost, creating financial barriers for healthcare providers and patients. The high cost may prevent the use of adhesion barriers in developing regions, potentially leading to mediocre patient consideration. This restraint emphasizes the urgent need for manufacturers to focus on cost-effective production methods and pricing strategies and for regulatory bodies to analyze reimbursement mechanisms that may enhance affordability access to these essential medical devices. Moreover, the presence of various risk factors, such as genetic polymorphisms related to the interleukin-1 receptor antagonist, increased estrogen exposure, and conditions such as endometriosis, significantly restrain post-operative adhesion development. These factors predispose individuals to an increased risk of adhesions, complicating the efficacy of preventive treatment and measures. Furthermore, multiple other factors known to promote fibrosis might indirectly boost the risk of adhesion development, adding complexity to the challenge of reducing post-operative adhesions further hindering market growth.

By Product Type

  • Synthetic Adhesion Barriers
    • Hyaluronic Acid
    • Regenerated Cellulose
    • Polyethylene Glycol
    • Other Synthetic Adhesion Barriers
  • Natural Adhesion Barriers
    • Collagen and Protein
    • Fibrin
    • Other

By Formulation

  • Film Formulations
  • Gel Formulations
  • Liquid Formulations

By Application

  • Gynecological Surgeries
  • General/Abdominal Surgeries
  • Orthopedic Surgeries
  • Cardiovascular Surgeries
  • Neurological Surgeries
  • Urological Surgeries
  • Reconstructive Surgeries
  • Other Surgeries

By Region

  • North America
  • Latin America
  • Europe
  • Asia-Pacific
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Due to the high prevalence of adhesion-related diseases, increasing surgical procedures, technological advancement, rising awareness about adhesion formation and adhesion-related diseases, and reimbursement standards incentivizing complex fusion surgery are anticipated to propel the growth of the adhesion barrier market over the forecast period. Additionally, adhesion barriers are also valuable for oncology surgeries. For instance, according to the data published by the American Academy of Orthopedic Surgeons in November 2022, approx 2,550,232 primary and revision hip and knee arthroplasty procedures were performed in the decade in the US. It showed a cumulative procedural volume growth of 14% compared to the previous year. As adhesion barriers are used for orthopedic procedures, increasing hip and knee arthroplasty procedures are expected to propel market growth during the projection period in the area.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Adhesion Barrier Market By Product Type, By Formulation, By Application and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches

 

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Adhesion Barrier Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Adhesion Barrier Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Adhesion Barrier Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Adhesion Barrier Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Synthetic Adhesion Barriers
         1.1. Hyaluronic Acid
         1.2. Regenerated Cellulose
         1.3. Polyethylene Glycol
         1.4. Other Synthetic Adhesion Barriers
        2. Natural Adhesion Barriers
         2.1. Collagen and Protein
         2.2. Fibrin
         2.3. Other

  • 8.   Adhesion Barrier Market, By Formulation Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Film Formulations
        2. Liquid Formulations
        3. Gel Formulations

  • 9.   Adhesion Barrier Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Gynecological Surgeries
        2. General/Abdominal Surgeries
        3. Cardiovascular Surgeries
        4. Orthopedic Surgeries
        5. Neurological Surgeries
        6. Reconstructive Surgeries
        7. Urological Surgeries
        8. Other Surgeries

  • 10.   North America Adhesion Barrier Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Adhesion Barrier Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Adhesion Barrier Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Adhesion Barrier Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Adhesion Barrier Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Johnson & Johnson
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Sanofi
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Baxter International
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. C. R. Bard
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Integra LifeSciences Holdings Corporation
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Anika Therapeutics
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Atrium Medical Corporation (A Part of Getinge Group)
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. FzioMed
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. MAST Biosurgery
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Innocoll Holdings
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Betatech Medical
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients